다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
Progress in pediatric cardiology, v.12 no.1, 2000년, pp.91 - 111
Grenier, Michelle A (Department of Pediatrics, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA) , Fioravanti, Joanne (Department of Pediatrics, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA) , Truesdell, Susie C (Department of Pediatrics, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA) , Mendelsohn, Alan M (Department of Pediatrics, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA) , Vermilion, Roger P (Department of Pediatrics, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA) , Lipshultz, Steven E (Department of Pediatrics, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA)
AI-Helper
AbstractAngiotensin-converting enzyme (ACE) inhibitors have become an important part of the pharmacologic armamentarium in the battle against treatment of ventricular dysfunction. There have been a number of large controlled, randomized trials in adults with both asymptomatic and symptomatic ventric...
N Engl J Med 325 293 1991 10.1056/NEJM199108013250501 Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure
N Engl J Med 316 1429 1987 10.1056/NEJM198706043162301 Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandanavian Enalapril Survival Study (CONSENSUS)
Am J Cardiol Redfield 74 737 1994 10.1016/0002-9149(94)90323-9 Natural history of incidentally discovered asymptomatic idiopathic dilated cardiomyopathy
N Engl J Med 327 685 1992 10.1056/NEJM199209033271003 Effect on enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions
Talner 1746 1995 Heart disease in infants, children, and adolescents including the fetus and young adult Heart failure
N Engl J Med Lipshultz 327 1260 1992 10.1056/NEJM199210293271802 Abnormal cardiac structure and function in HIV-infected children treated with zidovudine
J Am Coll Cardiol Lipshultz 25 54A 1995 10.1016/0735-1097(95)91678-Q Left ventricular structure and function eleven years after doxorubicin treatment for childhood leukemia: is this a restrictive cardiomyopathic process?
N Engl J Med Lipshultz 332 1738 1995 10.1056/NEJM199506293322602 Late cardiotoxicity following childhood malignancy: the effects of gender and doxorubicin dose
Mol Cell Biochem Beinleich 63/164 77 1996 10.1007/BF00408643 Role of bradykinin in the antihypertrophic effects of enalapril in the newborn pig heart
J Hypertens Cichoka 12 143 1994 The effect of ACE inhibition on left ventricular function and structure in hypertensive adolescents
J Cardiovasc Pharmacol Watanabe 32 248 1998 10.1097/00005344-199808000-00012 Chronic effects of enalapril and amlodipine on cardiac remodeling in cardiomyopathic hamster hearts
Clin Pharmacol Ther Nakamura 56 160 1994 10.1038/clpt.1994.119 The kinetic profiles of enalapril and enalaprilat and their possible developmental changes in pediatric patients with congestive heart failure
Arch Dis Child Scammel 62 1136 1987 10.1136/adc.62.11.1136 Plasma renin activity in infants with congenital heart disease
Acta Paediatr Scand Eronin 80 555 1990 10.1111/j.1651-2227.1991.tb11905.x Enalapril in children with congestive heart failure
Wiad Lek Rokicki 50 85 1997 Use of converting angiotensin inhibitors in children. II. Personal experience with enalapril
Acta Physiol Hungarica Bendig 72 121 1988 Indications and effects of captopril therapy in childhood
Arch Dis Child Frenneaux 64 219 1989 10.1136/adc.64.2.219 Enalapril for severe heart failure in infancy
Pediatr Cardiol Nedeljkovic 13 245 1992 Captopril (Zorkaptil) in treatment of heart failure due to CHD with pulmonary hypertension
Heart Failure Rev Dixon 2 107 1997 10.1023/A:1009771910953 Angiotensin II and TGF B in the development of cardiac fibrosis, myocyte hypertrophy and heart failure
Am J Cardiol Kichuk 70 137A 1997 10.1016/S0002-9149(97)00469-4 Angiotension-converting enzyme inhibitors promote nitric oxide production in coronary microvessels from failing explanted human hearts
J Mol Cell Cardiol Wamboldt 29 939 1997 10.1006/jmcc.1996.0336 Regression of cardiac hypertrophy normalizes glucose metabolism and left ventricular function during reperfusion
Miller K, Atkin B, Puppala B, Fisher M. Management of renal vascular hypertension in the high risk neonate with intravenous IV enalaprilat M-422. Interntl Sympos on ACE Inhibition 1989;F001.
J Pediatr Wells 117 664 1990 10.1016/S0022-3476(05)80711-5 Clinical and laboratory observations: treatment of neonatal hypertension with enalaprilat
Arch Inst Cardiol Mex Vazquez-Antyona 66 496 1996 Oral enalapril in symptomatic patients with interventricular septal defect
Am Heart J Brunner-La Rocca 138 654 1999 10.1016/S0002-8703(99)70179-1 Within-patient comparison of effects of different dosages of enalapril on functional capacity and neurohormone levels in patients with chronic heart failure
Med Clin North Am Rotmensch 72 399 1977 10.1016/S0025-7125(16)30776-3 Angiotensin-converting enzyme inhibitors
Drugs Moncloa 30 82 1985 10.2165/00003495-198500301-00012 Enalapril in hypertension and congestive heart failure: overall review of efficacy and safety
Pediatr Cardiol Schneeweiss 11 199 1990 10.1007/BF02238367 Cardiovascular drugs in children II. Angiotension-converting enzyme inhibitors in pediatric patients
J Pediatr Lloyd 114 650 1989 10.1016/S0022-3476(89)80715-2 Orally administered enalapril for infants with congestive heart failure: a dose-finding study
Arch Dis Child Leversha 70 35 1994 10.1136/adc.70.1.35 Efficacy and dosage of enalapril in congenital and acquired heart disease
Br J Clin Pharmacol Dutetre 35 528 1993 10.1111/j.1365-2125.1993.tb04180.x Inhibition of angiotensin converting enzyme with enalapril maleate in infants with congestive heart failure
J Pediatr Rheuban 117 668 1990 10.1016/S0022-3476(05)80712-7 Acute hemodynamic effects of converting enzyme inhibition in infants with congestive heart failure
Am J Cardiol Montigny 63 631 1989 10.1016/0002-9149(89)90915-6 Captopril in infants for congestive heart failure secondary to a large ventricular left-to-right shunt
Int J Cardiol Scammell 16 295 1987 10.1016/0167-5273(87)90153-7 Captopril in treatment of infant heart failure: a preliminary report
Arch Dis Child Shaw 63 360 1988 10.1136/adc.63.4.360 Captopril in heart failure secondary to a left to right shunt
AJDC Shaddy 142 100 1988 Short-term hemodynamic effects of captopril in infants with congestive heart failure
Pediatr Cardiol Webster 13 129 1992 10.1007/BF00793943 The acute haemodynamic effects of intravenous enalaprilat in children with intracardiac shunts
Eur Heart J Sluysman 13 88 1992 Intravenous enalaprilat and oral enalapril in heart failure secondary to a large ventricular septal defect in infants
J Am Coll Cardiol Lin 24 1046 1994 10.1016/0735-1097(94)90868-0 Vasodilator therapy in chronic asymptomatic aortic regurgitation: enalapril vs. hydralazine therapy
Am Heart J Alehan 135 598 1998 10.1016/S0002-8703(98)70273-X Beneficial effects of 1-year captopril therapy in children with chronic aortic regurgitation who have no symptoms
Cardiol Young Seguchi 2 14 1992 10.1017/S1047951100000524 Effect of enalapril on infants and children with congestive heart failure
Mund-Keifer-Und Gesichtschirurgerie Brandes 1 68 1997 10.1007/BF03043513 Life-threatening swelling of the tongue in antihypertensive therapy with ACE inhibitors
Drug Saf Parish 7 14 1992 10.2165/00002018-199207010-00004 Adverse effects of angiotensin converting (ACE) inhibitors: an update
Br J Clin Pharmacol Edwards 23 529 1987 10.1111/j.1365-2125.1987.tb03088.x Captopril: 4 years of post marketing surveillance of all patients in New Zealand
Zentralbl Gynakol Wacker 120 462 1998 Pregnancy in corrected transposition of great arteries and therapy with ACE inhibitors
J Tenn Med Assoc Krishna 89 5 1996 Acute renal failure associated with use of angiotensin converting enzyme inhibitor - a report of two children with Down Syndrome
Pediatr Cardiol Gleason 14 227 1993 10.1007/BF00795376 Captopril-induced bone marrow suppression in two cardiac patients with trisomy 21
Br Heart J Blackburn 69 5 76 1993 First dose haemodynamic effects of captopril in infants with left to right shunts
Am J Cardiol Sluysmans 70 959 1992 10.1016/0002-9149(92)90749-O Intravenous enalaprilat and oral enalapril in congestive heart failure secondary to ventricular septal defect in infancy
Inter J Cardiol Fallo 9 111 1985 10.1016/0167-5273(85)90411-5 Resistance to captopril in hypertension of coarctation of the aorta
Clin Exp Hyper Fallo A5 3 321 1983 10.3109/10641968309069491 Effect of captopril on blood pressure and on the renin-angiotensin-aldosterone system in coarctation of the aorta
Pediatrics Wood 88 4 816 1991 10.1542/peds.88.4.816 Captopril-induced reversible acute renal failure in an infant with coarctation of the aorta
Angiology Ashizawa 36 197 1985 10.1177/000331978503600309 A case of aortitis syndrome with severe coarctation of the aorta
Clin Res Jenkins 33 122A 1985 Treatment of neonatal hypertension with captopril
Clin Exp Hypertens Loirat A8 805 1986 10.3109/10641968609046598 Sequential echocardiographic study prior and during antihypertensive therapy in children with severe hypertension
J Hum Hypertens Loirat 8 398 1994 Value of ambulatory blood pressure monitoring and echocardiography in the management of children with high blood pressure
Arch Dis Child McGonigle 62 614 1987 10.1136/adc.62.6.614 Recovery from neonatal myocardial dysfunction after treatment of acute hypertension
Pediatr Clin North Am Sinaiko 40 195 1993 10.1016/S0031-3955(16)38490-5 Pharmacologic management of childhood hypertension
Postgrad Med J Woodmansey 70 927 1994 10.1136/pgmj.70.830.927 Acute renal failure with ACE inhibition in aortic coarctation
Cleveland Clin J Med Brouhard 62 21 1995 10.3949/ccjm.62.1.21 Hypertension in children and adolescents
Physician Sports Med Daniels 20 97 1992 Hypertension in children and adolescents. Part II: Pharmacologic control - what works and why
Mayo Clin Proc Lieberman 69 1098 1994 10.1016/S0025-6196(12)61379-2 Pediatric hypertension: clinical perspective
Gersony 243 1989 Heart disease in infants, children and adolescents Coarctation of the aorta
Hypertension Bagby 13 91 1989 10.1161/01.HYP.13.2.91 Chronic MK421 fails to modify evolution of hypertension in neonatally coarcted pups
J Lab Clin Med Bailie 104 553 1984 Role of the renin-angiotensin system in hypertension after coarctation of the aorta
Am J Cardiol Alpert 43 828 1979 10.1016/0002-9149(79)90085-7 Role of the renin-angiotensin-aldosterone system in hypertensive children with coarctation of the aorta
Am J Hypertens Kromer 4 521 1991 10.1093/ajh/4.6.521 Role of neurohumoral systems for pressure induced left ventricular hypertrophy in experimental supravalvar aortic stenosis in rats
Caraballo 563 1998 Comprehensive cardiovascular medicine Aortic valve disease
Int J Cardiol Ohuchi 66 241 1998 10.1016/S0167-5273(98)00249-6 Cardiorespiratory response during exercise in patents with cyanotic congenital heart disease with and without a Fontan operation and in patients with congestive heart failure
Am J Cardiol Hopkins 77 439 1996 10.1016/S0002-9149(97)89382-4 Angiotensin-converting enzyme inhibitors in adults with cyanotic congenital heart disease
Clin Nephrol Watanabe 45 362 1996 Angiotensin converting enzyme inhibitor improves nephrotic syndrome associated with cyanotic congenital heart disease
J Am Coll Cardiol Akagi 20 920 1992 10.1016/0735-1097(92)90194-R Ventricular performance before and after Fontan repair for univentricular atrioventricular connection: angiographic and radionuclide assessment
Circulation Kouatli 96 1507 1997 10.1161/01.CIR.96.5.1507 Enalapril does not enhance exercise capacity in patients after Fontan procedure
Pediatr Res Troutman 39A 39A 1996 10.1203/00006450-199604001-00237 Effects of Enalapril on exercise and end systolic ventricular wall stress in the Fontan patient
10.1161/01.CIR.83.2.523 Bengur A.R., Beekman R.H., Rocchini A.P., Crowley D.P., Schork M.A., Rosenthal. Acute hemodynamic effects of captopril in children with a congestive or restrictive cardiomyopathy. Circulation 1991;83:523-527.
Pediatr Cardiol Stern 11 22 1990 10.1007/BF02239543 Captopril in children with dilated cardiomyopathy: acute and long-term effects in a prospective study of hemodynamic and hormonal effects
Z Kardiol Schiffman 85 709 1996 Treatment effects of captopril in neonates, infants and young children with congestive heart failure
Pediatr Cardiol Lewis 14 9 1993 10.1007/BF00794837 The effect of treatment with angiotensin-converting enzyme inhibitors on survival of pediatric patients with dilated cardiomyopathy
Am J Phys Med Rehabil Ishikawa 74 345 1995 10.1097/00002060-199509000-00005 A management trial for Duchenne cardiomyopathy
Anuroj K, Pathmanand C, Seublinvong, Thisyakorn C, Chotivitayatarkorn P. Ventricular functions in children with human immunodeficiency virus infection after ACE-inhibitors. Southeast Asian J Trop Med Public Health 1997;28:375-379.
10.1161/01.CIR.83.2.707 Latson LA. Captopril in children with cardiomyopathies (editorial). Circulation 1991;83:707-708.
Circulation Kyriakidis 97 1342 1998 10.1161/01.CIR.97.14.1342 Effects of cardiac vs. circulatory angiotensin-converting enzyme inhibition of left ventricular diastolic dysfunction and coronary blood flow in hypertrophic cardiomyopathy
Circulation Mori 96 8 1436 1997 Angiotensin converting enzyme inhibitor reduces left ventricular muscle mass in volume overloaded heart during growth
Circulation Cuthbertson 90 1-50 105 1994 Anthracycline cardiotoxicity in children with cancer
Circulation Lipshultz 84 II 659 1991 Afterload reduction therapy in long term survivors of childhood cancer treated with doxorubicin
Circulation Lipshultz 96 I 436 1997 Is enalapril beneficial in doxorubicin-treated long-term survivors of childhood cancer?
Circulation Schunkert 87 1328 1993 10.1161/01.CIR.87.4.1328 Distribution and functional significance of cardiac angiotensin converting enzyme in hypertrophied rat hearts
Med Pediatr Oncol Pihkala 23 247 1994 Therapy of severe anthracycline (A) cardiomyopathy with digoxin and enalapril: a follow-up study of 13 children
Pediatr Nephrol Irwin 6 448 1992 10.1007/BF00874011 Effects of enalapril on Adriamycin-induced nephrosis
Lancet 342 821 1993 Effect of ramipramil on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure
N Engl J Med Pfeffer 327 669 1992 10.1056/NEJM199209033271001 Effect of captopril on morbidity and mortality in patients with left ventricular dysfunction after myocardial infarction
Cardiology Maisch 87 2 1996 10.1159/000177160 Ventricular remodeling
Jpn Circ J Yanagishsita 61 161 1997 10.1253/jcj.61.161 Protective effect of captopril on ischemic myocardium
Jpn Heart J Shinohara 39 97 1998 10.1536/ihj.39.97 Collagen synthesis by cultured cardiac fibroblasts obtained from cardiomyopathic hamsters
J Cardiovasc Pharmacol Narita 27 861 1996 10.1097/00005344-199606000-00014 Prolonging action of imidapril on the lifespan expectancy of cardiomyopathic hamsters
Heart Boldt 76 189 1996 10.1136/hrt.76.3.207 Can clonidine, enoximine, and enalaprilat help to protect the myocardium against ischaemia in cardiac surgery?
해당 논문의 주제분야에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.